Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 170

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825

Open access
Gittleman, Haley, Lim, Daniel, Kattan, Michael W., Chakravarti, Arnab, Gilbert, Mark R., Lassman, Andrew B., Lo, Simon S., Machtay, Mitchell, Sloan, Andrew E., Sulman, Erik P, Tian, Devin, Vogelbaum, Michael A., Wang, Tony J. C., Penas-Prado, Marta, Youssef, Emad, Blumenthal, Deborah T., Zhang, Peixin, Mehta, Minesh P., Barnholtz-Sloan, Jill S. · 2016 · Neuro-Oncology

Abstract

Background: Glioblastoma (GBM) is the most common primary malignant brain tumor. Nomograms are often used for individualized estimation of prognosis. This study aimed to build and independently validate a nomogram to estimate individualized survival probabilities for patients with newly diagnosed GBM, using data from 2 independent NRG Oncology Radiation Therapy Oncology Group (RTOG) clinical trials. Methods: This analysis included information on 799 (RTOG 0525) and 555 (RTOG 0825) eligible and randomized patients with newly diagnosed GBM and contained the following variables: age at diagnosis, race, gender, Karnofsky performance status (KPS), extent of resection, O6-methylguanine-DNA methyltransferase (MGMT) methylation status, and survival (in months). Survival was assessed using Cox proportional hazards regression, random survival forests, and recursive partitioning analysis, with adjustment for known prognostic factors. The models were developed using the 0525 data and were independently validated using the 0825 data. Models were internally validated using 10-fold cross-validation, and individually predicted 6-, 12-, and 24-month survival probabilities were generated to measure the predictive accuracy and calibration against the actual survival status. Results: A final nomogram was built using the Cox proportional hazards model. Factors that increased the probability of shorter survival included greater age at diagnosis, male gender, lower KPS, not having total resection, and unmethylated MGMT status. Conclusions: A nomogram that assesses individualized survival probabilities (6-, 12-, and 24-mo) for patients with newly diagnosed GBM could be useful to health care providers for counseling patients regarding treatment decisions and optimizing therapeutic approaches. Free software for implementing this nomogram is provided: http://cancer4.case.edu/rCalculator/rCalculator.html.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/neuonc/now208

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 16

  1. 10.1093/neuonc/nov189 · DOI · Paper page
  2. 10.1056/NEJMoa043331 · DOI · Paper page
  3. 10.1016/S1470-2045(09)70025-7 · DOI · Paper page
  4. 10.1002/cncr.29575 · DOI
  5. 10.1093/neuonc/nos087 · DOI
  6. 10.1016/S1470-2045(07)70384-4 · DOI · Paper page
  7. 10.1093/jnci/85.9.704 · DOI · Paper page
  8. 10.1016/j.ijrobp.2010.06.012 · DOI · Paper page
  9. 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4 · doi:10.1002/(sici)1097-0258(19960229)15:4<361::aid-sim168>3.0.co;2-4
  10. 10.3171/jns.2001.95.2.0190 · DOI · Paper page
  11. 10.1158/1055-9965.EPI-14-0275 · DOI · Paper page
  12. 10.1016/j.ccr.2006.02.019 · DOI · Paper page
  13. 10.1200/JCO.2007.11.5964 · DOI · Paper page
  14. 10.4103/0028-3886.79128 · DOI
  15. 10.1002/cncr.21539 · DOI · Paper page
  16. 10.1002/1097-0142(19850815)56:4<894::AID-CNCR2820560432>3.0.CO;2-# · doi:10.1002/1097-0142(19850815)56:4<894::aid-cncr2820560432>3.0.co;2-#

Cited by

See all 170

Metadata

Authors
Gittleman, H., Lim, D., Kattan, M. W., Chakravarti, A., Gilbert, M. R., Lassman, A. B., Lo, S. S., Machtay, M., Sloan, A. E., Sulman, E. P., Tian, D., Vogelbaum, M. A., Wang, T. J. C., Penas-Prado, M., Youssef, E., Blumenthal, D. T., Zhang, P., Mehta, M. P., & Barnholtz-Sloan, J. S.
Venue
Neuro-Oncology
Published
2016-09-23
Volume
19
Issue
5
Pages
now208
ISSN
  • 1522-8517 (ISSN-L)
  • 1523-5866
OpenAlex
W2521224740
Cited by
170
References
5
FWCI
9.90
Type
journal article
Language
en
Open access
green
Funders
National Cancer Institute

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825. https://app.cochat.ai/papers/10.1093/neuonc/now208
The paper
Gittleman, H., Lim, D., Kattan, M. W., Chakravarti, A., Gilbert, M. R., Lassman, A. B., Lo, S. S., Machtay, M., Sloan, A. E., Sulman, E. P., Tian, D., Vogelbaum, M. A., Wang, T. J. C., Penas-Prado, M., Youssef, E., Blumenthal, D. T., Zhang, P., Mehta, M. P., & Barnholtz-Sloan, J. S. (2016). An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825. Neuro-Oncology. https://doi.org/10.1093/neuonc/now208

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.